After a huge IPO and acquisition, Zymergen caps off bankruptcy with $30M SEC penalty

The rise and fall of the short-lived biotech Zymergen has ended with a $30 million penalty from the SEC.

Zymergen’s rise began in April 2021 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Dana-Farber expands studies to be retracted to 6, plus 31 to be corrected over mishandled data

A review of alleged data manipulation in studies involving four top scientists at Dana-Farber Cancer Institute has led to plans to retract six papers and

January 22, 2024

Did CDC Recommend a Second Dose of the New COVID Vaccine for All Adults?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

October 27, 2024

Azenta in robotics: Theme innovation strategy

Share this article Azenta grant share with robotics as a theme is 70% in Q4 2023. Grant share is based on the ratio of number

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.